{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:39Z","timestamp":1792831059608,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["C\\u00D3DIGO n\\u00B0: 01.24.0610.00"],"award-info":[{"award-number":["C\\u00D3DIGO n\\u00B0: 01.24.0610.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["process number E-26\/204.367\/2024"],"award-info":[{"award-number":["process number E-26\/204.367\/2024"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110631","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:47Z","timestamp":1791389027000},"page":"110631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Photoredox and PIFA-mediated synthesis of N-aryl azacoumestanes: Antileukemic activity and venetoclax synergism in acute myeloid leukemia"],"prefix":"10.1016","volume":"183","author":[{"given":"Rachel C.V.","family":"Novas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 de Brito V.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana T.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa M.","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"de Sousa Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos K.","family":"Paier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo S.A.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla D.","family":"Buarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110631_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110631_bb0010","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","article-title":"The global, regional, and national burden of cancer, 1990\u20132023: a systematic analysis for the global burden of disease study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110631_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.31557\/apjcb.2023.8.1.75-89","article-title":"Epigenetics and cancer: a comprehensive review","volume":"8","author":"Pathak","year":"2023","journal-title":"Asian Pac. J. Cancer Biol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.110631_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184360","article-title":"Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study","volume":"12","author":"Pearce","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110631_bb0030","article-title":"Therapeutic resistance in leukemia: mechanisms and strategies to overcome","volume":"13","author":"Richter","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0035","series-title":"Fortschritte der Chemie organischer naturstoffe\/progress in the chemistry of organic natural products","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7091-6172-2_1","article-title":"The naturally occurring coumarins","author":"Murray","year":"2002"},{"key":"10.1016\/j.bioorg.2026.110631_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051604","article-title":"An update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents","volume":"27","author":"Rubab","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110631_bb0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2015.07.010","article-title":"Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies","volume":"101","author":"Thakur","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25143251","article-title":"Synthesis and evaluation of new coumarin derivatives as antioxidant, antimicrobial, and anti-inflammatory agents","volume":"25","author":"Alshibl","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110631_bb0055","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2174\/1381612043382710","article-title":"Natural and synthetic coumarin derivatives with anti-inflammatory\/antioxidant activities","volume":"10","author":"Fylaktakidou","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2026.110631_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061465","article-title":"Antagonists of vitamin K\u2014popular coumarin drugs and new synthetic and natural coumarin derivatives","volume":"25","author":"Kasperkiewicz","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110631_bb0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/14756366.2021.2024526","article-title":"Research progress of coumarins and their derivatives in the treatment of diabetes","volume":"37","author":"Pan","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0070","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/jphp.12774","article-title":"Coumarins as potential antidiabetic agents","volume":"69","author":"Li","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032839","article-title":"Plant coumarins with anti-HIV activity: isolation and mechanisms of action","volume":"24","author":"Sharapov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110631_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104863","article-title":"Coumarin-based derivatives with potential anti-HIV activity","volume":"150","author":"Xu","year":"2021","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2026.110631_bb0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bmcl.2017.01.013","article-title":"Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents","volume":"27","author":"Luo","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110631_bb0090","article-title":"The predicted models of anti-colon cancer and anti-hepatoma activities of substituted 4-anilino coumarin derivatives using quantitative structure-activity relationship (QSAR)","volume":"34","author":"Putri","year":"2022","journal-title":"J. King Saud Univ. - Sci."},{"key":"10.1016\/j.bioorg.2026.110631_bb0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejmech.2017.05.004","article-title":"Recent developments of coumarin-containing derivatives and their anti-tubercular activity","volume":"136","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0100","first-page":"1","article-title":"An in vitro coumarin-antibiotic combination treatment of Pseudomonas aeruginosa biofilms","volume":"16","author":"Zou","year":"2021","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.bioorg.2026.110631_bb0105","article-title":"Neuroprotective action of coumarin derivatives through activation of TRKB-CREB-BDNF pathway and reduction of caspase activity in neuronal cells expressing pro-aggregated tau protein","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110631_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105141","article-title":"Synthesis of 3-aryl-4-(N-aryl)aminocoumarins via photoredox arylation and the evaluation of their biological activity","volume":"114","author":"Carneiro","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110631_bb0115","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.3390\/molecules18066620","article-title":"Biomedical importance of indoles","volume":"18","author":"Kaushik","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110631_bb0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00810008","article-title":"Synthese von Indolen und Isochinolonen aus Phenylmalonylheterocyclen","volume":"115","author":"Stadlbauer","year":"1984","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0125","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2015.10.021","article-title":"Synthesis and anticancer activity of 6-heteroarylcoumarins","volume":"105","author":"Galayev","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bioorg.2015.10.001","article-title":"Some new indole\u2013coumarin hybrids; synthesis, anticancer and Bcl-2 docking studies","volume":"63","author":"Kamath","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0140","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/acs.jmedchem.6b00158","article-title":"Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: A novel class of potent tubulin polymerization inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102050","article-title":"Coumarin hybrid derivatives as promising leads to treat tuberculosis: recent developments and critical aspects of structural design to exhibit anti-tubercular activity","volume":"127","author":"Reddy","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bioorg.2026.110631_bb0150","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.bmcl.2007.05.104","article-title":"In-silico fragment-based identification of novel angiogenesis inhibitors","volume":"17","author":"Dakshanamurthy","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110631_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bmc.2018.11.037","article-title":"Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g]benzopyrano[4,3-b]indol-6(13H)-one scaffold","volume":"27","author":"Fukuda","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110631_bb0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF00815924","article-title":"Potential non-steroidal estrogens and antiestrogens, part IV organic azides in heterocyclic synthesis: synthesis of aza-and diazacoumestrols via azido derivatives","volume":"122","author":"Stadlbauer","year":"1991","journal-title":"Monatsh. Chem."},{"issue":"42","key":"10.1016\/j.bioorg.2026.110631_bb0165","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1016\/j.tetlet.2013.08.030","article-title":"A convenient approach to the design and synthesis of indolo [3,2-c] coumarins via the microwave-assisted Cadogan 115 reaction","volume":"54","author":"Irgashev","year":"2013","journal-title":"Tetrahedron Lett."},{"issue":"22","key":"10.1016\/j.bioorg.2026.110631_bb0170","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1021\/acs.joc.6b02160","article-title":"Access to indole-fused polyheterocycles via Pd-catalyzed base-free intramolecular cross dehydrogenative coupling","volume":"81","author":"Cheng","year":"2016","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0175","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bioorg.2018.07.004","article-title":"11a-N-tosyl-5-carbapterocarpans: synthesis, antineoplastic evaluation and in silico prediction of ADMETox properties","volume":"80","author":"Mendes","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0180","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1021\/ol062288o","article-title":"Synthesis of N-substituted indole derivatives via PIFA-mediated intramolecular cyclization","volume":"8","author":"Du","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.110631_bb0185","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/jacs.6b04057","article-title":"Hydrogen bonding to hexafluoroisopropanol controls the oxidative strength of hypervalent iodine reagents","volume":"138","author":"Colomer","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110631_bb0190","article-title":"Repositioning of antiparasitic drugs for tumor treatment","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105207","article-title":"Ivermectin, a potential anticancer drug derived from an antiparasitic drug","volume":"163","author":"Tang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.110631_bb0200","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2217\/fon.14.65","article-title":"Mutual action of anticancer and Antiparasitic drugs: are there any shared targets?","volume":"10","author":"Dorosti","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2022.280801","article-title":"The clinical impact of the molecular landscape of acute myeloid leukemia","volume":"108","author":"Kayser","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.bioorg.2026.110631_bb0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40364-024-00649-y","article-title":"Global, regional, and national burden of acute myeloid leukemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"12","author":"Zhou","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bioorg.2026.110631_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3324\/haematol.2021.280161","article-title":"The \"7+3\" regimen in acute myeloid leukemia","volume":"107","author":"Rowe","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.bioorg.2026.110631_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.htct.2023.07.007","article-title":"Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine","volume":"46","author":"Lopes","year":"2024","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"10.1016\/j.bioorg.2026.110631_bb0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.bioorg.2026.110631_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103281","article-title":"Update on drug transporter proteins in acute myeloid leukemia: pathological implication and clinical setting","volume":"160","author":"Vasconcelos","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4155\/fmc.14.50","article-title":"Conformational restriction: an effective tactic in 'follow-on'-based drug discovery","volume":"6","author":"Fang","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0240","first-page":"5447","article-title":"Selective anticancer activity of neurotoxin 1-methyl-4-phenylpyridinium on non-small cell lung adenocarcinoma A549 cells","volume":"34","author":"Badisa","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2026.110631_bb0245","article-title":"High metabolic dependence on oxidative phosphorylation drives sensitivity to metformin treatment in MLL\/AF9 acute myeloid leukemia","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110631_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1851-3","article-title":"A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs","volume":"10","author":"Panina","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110631_bb0255","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ccell.2020.10.010","article-title":"Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia","volume":"38","author":"Bhatt","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110631_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2017.00096","article-title":"Perspectives on systems modeling of human peripheral blood mononuclear cells","volume":"4","author":"Sen","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2026.110631_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genomics Proteomics Bioinf."},{"key":"10.1016\/j.bioorg.2026.110631_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0280","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110631_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102467","article-title":"Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations","volume":"59","author":"Yang","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s10020-022-00565-7","article-title":"Zeng, A novel mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells","volume":"29","author":"Zhao","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.bioorg.2026.110631_bb0295","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/molecules24010096","article-title":"MHY440, a novel topoisomerase I inhibitor, induces cell cycle arrest and apoptosis via a ROS-dependent DNA damage signaling pathway in AGS human gastric cancer cells","volume":"24","author":"Jang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110631_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3324\/haematol.2010.032680","article-title":"The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine","volume":"96","author":"Walsby","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bioorg.2026.110631_bb0305","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"L\u00f6wenberg","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110631_bb0310","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin\u2014an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.110631_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/membranes13110851","article-title":"Advances in computational approaches for estimating passive permeability in drug discovery","volume":"13","author":"Bernardi","year":"2023","journal-title":"Membranes"},{"key":"10.1016\/j.bioorg.2026.110631_bb0325","first-page":"1","article-title":"Organic anion transporting polypeptide 1B1 (OATP1B1): a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"76","author":"Niemi","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2026.110631_bb0330","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/mp300555n","article-title":"Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux","volume":"10","author":"Desai","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2026.110631_bb0335","article-title":"Development of simple and accurate in silico ligand-based models for predicting ABCG2 inhibition","volume":"10","author":"Huang","year":"2022","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110631_bb0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2133\/dmpk.25.170","article-title":"Inhibitory effects of herbal extracts on breast cancer resistance protein (BCRP) and structure\u2013inhibitory potency relationship of isoflavonoids","volume":"25","author":"Tamaki","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110631_bb0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-004-0914-y","article-title":"Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin","volume":"56","author":"Barthomeuf","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110631_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29020287","article-title":"Modeling the blood\u2013brain barrier permeability of potential heterocyclic drugs via biomimetic IAM chromatography combined with QSAR methodology","volume":"29","author":"Janicka","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110631_bb0355","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.xphs.2020.08.023","article-title":"In silico models of human pharmacokinetic parameters: prediction of volume of distribution using an extensive data set and a reduced number of parameters","volume":"110","author":"Berellini","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110631_bb0360","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/17460441.2021.1961741","article-title":"An update on the importance of plasma protein binding in drug discovery and development","volume":"16","author":"Di","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110631_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-99766-3","article-title":"hERG toxicity prediction in early drug discovery using extreme gradient boosting and isometric stratified ensemble mapping","author":"Falc\u00f3n-Cano","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110631_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110631_bb0375","first-page":"936","article-title":"Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110631_bb0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110631_bb0385","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/nprot.2007.397","article-title":"Assay for apoptosis using the mitochondrial probes, rhodamine 123 and 10-N-nonyl acridine orange","volume":"2","author":"Ferlini","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.110631_bb0390","author":"Simulations Plus"},{"key":"10.1016\/j.bioorg.2026.110631_bb0395","author":"Simulations Plus"},{"key":"10.1016\/j.bioorg.2026.110631_bb0400","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110631_bb0405","doi-asserted-by":"crossref","first-page":"W469","DOI":"10.1093\/nar\/gkae254","article-title":"Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction","volume":"52","author":"Myung","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110631_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110631_bb0415","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a web server for toxicity prediction of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:07:26Z","timestamp":1792829246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826011673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":82,"alternative-id":["S0045206826011673"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110631","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photoredox and PIFA-mediated synthesis of N-aryl azacoumestanes: Antileukemic activity and venetoclax synergism in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110631"}}